Literature DB >> 8305896

Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels.

N Martin-Moutot1, O el Far, C Leveque, P David, B Marqueze, B Lang, J Newsom-Davis, T Hoshino, M Takahashi, M J Seagar.   

Abstract

Plasma from patients with Lambert-Eaton myasthenic syndrome (LEMS), an autoimmune disease of neuromuscular transmission, contains antibodies that immunoprecipitate 125I-omega-conotoxin GVIA labeled-calcium channels solubilized from rat brain. These antibodies label a 58-kDa protein in Western blots of partially purified 125I-omega-conotoxin receptor preparations. Monoclonal antibody 1D12, produced by immunizing mice with synaptic membranes, has similar properties as these LEMS IgG. 1D12 antigen was purified by immunoaffinity chromatography and shown to bind LEMS IgG. The antigen was identified by immunoscreening a rat brain cDNA library with mAb 1D12 and found to have strong homology to the synaptic vesicle protein synaptotagmin. These antibodies immunoprecipitate calcium channels by binding to synpatotagmin, an associated protein. We suggest that the interaction between synaptotagmin and omega-conotoxin sensitive calcium channels plays a role in docking synaptic vesicles at the plasma membrane prior to rapid neurotransmitter release. Autoantibody binding to a synaptotagmin-calcium channel complex may be involved in the etiology of LEMS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305896     DOI: 10.1016/0928-4257(93)90022-l

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  5 in total

Review 1.  Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.

Authors:  Stephen D Meriney; Tyler B Tarr; Kristine S Ojala; Man Wu; Yizhi Li; David Lacomis; Adolfo Garcia-Ocaña; Mary Liang; Guillermo Valdomir; Peter Wipf
Journal:  Ann N Y Acad Sci       Date:  2017-11-10       Impact factor: 5.691

2.  Mouse δ opioid receptors are located on presynaptic afferents to hippocampal pyramidal cells.

Authors:  Xavier Rezaï; Lauren Faget; Ewa Bednarek; Yannick Schwab; Brigitte L Kieffer; Dominique Massotte
Journal:  Cell Mol Neurobiol       Date:  2012-01-18       Impact factor: 5.046

Review 3.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

4.  Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitis.

Authors:  Margarete E Swadzba; Stefanie M Hauck; Hassan Y Naim; Barbara Amann; Cornelia A Deeg
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Gastric cancer complicated by paraneoplastic neurological syndrome which presented with extremity numbness: a case report.

Authors:  Takuto Yoshida; Hideki Kawamura; Kazuhiro Mino; Yuji Konishi; Tomoya Saito; Yuichi Shimizu; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2022-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.